MUMBAI, India, March 14 -- Intellectual Property India has published a patent application (202617004122 A) filed by Iksuda Therapeutics Limited, Newcastle Upon Tyne, U.K., on Jan. 15, for 'co-administration of antibody-drug conjugate.'
Inventor(s) include Lodge, Adam; Deckert, Jutta; Lutz, Robert; and Mysliwy, Justyna.
The application for the patent was published on March 13, under issue no. 11/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to antibody-drug conjugates (ADCs) that target the CanAg antigen and co-administration of the ADC with unconjugated antibody. In particular, the present invention relates to compositions (e.g. pharmaceutical compositions) comprising the ADCs...